WHO International Meeting of World Pharmacopoeias publishes Favipiravir and Favipiravir Tablets monographs for comment
The World Health Organisation’s (WHO) International Meeting of World Pharmacopoeias (IMWP) has published draft monographs for Favipiravir and Favipiravir Tablets for public comment. These non-mandatory monographs were developed by the IMWP as a resource to aid independent users in their assurance of medicines quality.
The commenting period closes on 11 June 2021.